Suche Bilder Maps Play YouTube News Gmail Drive Mehr »
Einstellungen | Anmelden

Business Development Manager API Acti...

Echtzeit-Berichte

Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland Pharma

Economic Times - ‎28.07.2016‎
Ravi Penmetsa, Managing Director at Gland Pharma has helmed the specialty injectable drug maker for nearly two decades. From the start, the Hyderabad-based firm chose to ... to sell Gland Pharma to a Chinese company? Over the years, Gland built strong ...

Cambrex Corporation (CBM) Releases Earnings Results, Beats Expectations By $0.13 EPS

Market Digest - ‎vor 12 Stunden‎
In a different news, on Jul 11, 2016, William B Korb (director) sold 3,420 shares at $55.00 per share price. According to the SEC, on May 10, 2016, ... Cambrex Corporation (Cambrex) is a life sciences company that provides products and services for the ...

New Broker Ratings For Alexza Pharmaceuticals, Inc. (ALXA)

FTSE News - ‎vor 5 Stunden‎
The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients ...

Albany Molecular Research (NASDAQ:AMRI) Short Interest Decreased By 0.28%

Press Telegraph - ‎vor 5 Stunden‎
The stock of Albany Molecular Research (NASDAQ:AMRI) registered a decrease of 0.28% in short interest. AMRI's total short interest was 5.51 million shares in July as published by FINRA.

SK Capital Announces New Organizational Structure and Expanded Leadership Team at Noramco and Tasmanian ...

Business Wire (press release) - ‎20.07.2016‎
... a disciplined focus on the specialty materials, chemicals and healthcare sectors, announced a new organizational structure and additions to the senior management team of the firm's recently acquired specialty active pharmaceutical ingredient (“API ...

FDA adds 4 API manufacturers to 'Red List'

In-PharmaTechnologist.com - ‎19.07.2016‎
Fleming Laboratories Limited , an India-based active pharmaceutical ingredient (API) manufacturer, told us the company was previously audited by European Authorities (EDQM and EUGMP) in 2010 and 2013. According to the company, Fleming failed the ...

Albany Molecular Research Inc. Expected to Earn Q3 2016 Earnings of $0.26 Per Share (AMRI)

BBNS - ‎27.07.2016‎
The Company provides drug discovery, development, and manufacturing services. The Company operates through three segments: Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing (DPM) ...

Lannett Announces Receipt Of FDA Acceptable Filing Letter For Fentanyl Patch ANDA

PR Newswire (press release) - ‎20.07.2016‎
"Expanding our pain management franchise is a key component of our growth strategy," said Arthur Bedrosian, chief executive officer of Lannett.

Stocks Under Review: CVS Health (CVS), Mylan N.V. (MYL) Radian (RDN)

iStreetWire - ‎vor 4 Stunden‎
The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream, or ointment forms, as well as active pharmaceutical ingredients (APIs). It is also involved in the development of ...
Echtzeit-Berichte

Biocon Q1 net rises 35% to Rs167 crore

Livemint - ‎21.07.2016‎
“Our strong performance this quarter has been driven by an all-round growth of our business across small molecules, biologics, branded formulations and research services,” said Kiran Mazumdar-Shaw, chairperson and managing director of Biocon. ... The ...
Echtzeit-Berichte

Johnson Matthey 1Q trading update

Energy Global - ‎21.07.2016‎
In services, precious metals management's sales increased as the business benefited from the volatility in platinum group metal (pgm) prices during the period.

Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids

GlobeNewswire (press release) - ‎18.07.2016‎
PARIS, BOSTON, and PORT HUENEME, Calif., July 19, 2016 (GLOBE NEWSWIRE) -- NEOVACS (Alternext Paris:ALNEV) and STELLAR BIOTECHNOLOGIES Inc. (Nasdaq:SBOT) today announced the start of their joint venture company, Neostell SAS, with ...

Dr Reddy's facing tough times but set to overcome with investments in R&D for new drugs

pharmabiz.com - ‎24.07.2016‎
Dr Reddy's Laboratories (DRL), the second largest Indian pharma major with consolidated net sales of Rs.15,400 crore plus, has set to overcome challenging circumstances with higher investment in research and development, focus on operational excellence ...

Albany Molecular Research, Inc. (NASDAQ:AMRI) Current Analyst Ratings

Fiscal Standard - ‎27.07.2016‎
The Company provides drug discovery, development, and manufacturing services. The Company operates through three segments: Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing (DPM) ...

Moleculin Announces Successful Engineering Run for Production of Annamycin

Marketwired (press release) - ‎19.07.2016‎
HOUSTON, TX --(Marketwired - July 19, 2016) - Moleculin Biotech, Inc., ( NASDAQ : MBRX) ("Moleculin" or the "Company"), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are ...

Stock's Trend Analysis Report: Kellogg Company (K), Mylan N.V. (MYL), Fairmount Santrol Holdings Inc. (FMSA)

iStreetWire - ‎28.07.2016‎
The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream, or ointment forms, as well as active pharmaceutical ingredients (APIs). It is also involved in the development of ...

Radius Health Announces Multiple Presentations at the American Society for Bone and Mineral Research 2016 Annual ...

PharmiWeb.com (press release) - ‎20.07.2016‎
Radius Health entered into agreements with Lonza Sales Ltd., Vetter Pharma International GmbH and Ypsomed AG for commercial supply of abaloparatide-SC, the Company's lead investigational drug product. Lonza will manufacture the commercial supply of the ...

Radient Technologies Inc. Announces Appointment of Dimitris Tzanis to Board of Directors

SYS-CON Media (press release) - ‎26.07.2016‎
He has over twenty years of experience in conceiving, developing and promoting ideas and insights. Through his time in London, New York, Athens and Zurich he has provided his services as a film and TV director for large events for 20 years, 15 years of ...

Albany Molecular Research, Inc. (NASDAQ:AMRI) Updated Price Targets

FTSE News - ‎25.07.2016‎
02/21/2014 - Albany Molecular Research, Inc. was upgraded to “buy” by analysts at McLean Capital Management. Albany Molecular Research, Inc. has a 50 day moving average of 14.09 and a 200 day moving average of 14.98.

Albany Molecular Research, Inc. (NASDAQ:AMRI) Broker Price Targets For The Coming Week

Fiscal Standard - ‎24.07.2016‎
02/21/2014 - Albany Molecular Research, Inc. was upgraded to “buy” by analysts at McLean Capital Management. Albany Molecular Research, Inc. has a 50 day moving average of 14.09 and a 200 day moving average of 14.98.
 -